Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34850167

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Neuro Oncol
Publication date
2022 Jun 1
First author
Doz F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Neuro Oncol. 2022 Jun 1;24(6):1008-1009. doi: 10.1093/neuonc/noac048.
    note
    Source null
    related pmid
    35178549
    relationship
    Comment in

Authors and identifiers

  1. name
    Doz F
    type
    Author
  2. name
    van Tilburg CM
    type
    Author
  3. name
    Geoerger B
    type
    Author
  4. name
    Højgaard M
    type
    Author
  5. name
    Øra I
    type
    Author
  6. name
    Boni V
    type
    Author
  7. name
    Capra M
    type
    Author
  8. name
    Chisholm J
    type
    Author
  9. name
    Chung HC
    type
    Author
  10. name
    DuBois SG
    type
    Author
  11. name
    Gallego-Melcon S
    type
    Author
  12. name
    Gerber NU
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Doz F
    type
    Author
  2. name
    van Tilburg CM
    type
    Author
  3. name
    Geoerger B
    type
    Author
  4. name
    Højgaard M
    type
    Author
  5. name
    Øra I
    type
    Author
  6. name
    Boni V
    type
    Author
  7. name
    Capra M
    type
    Author
  8. name
    Chisholm J
    type
    Author
  9. name
    Chung HC
    type
    Author
  10. name
    DuBois SG
    type
    Author
  11. name
    Gallego-Melcon S
    type
    Author
  12. name
    Gerber NU
    type
    Author
bibliography ids
  1. nci-bib-55007ef7cf4b78a2fcb03622
book metadata
content sha256
42e6fb1f8fbcb06cb20db930c58015cad83037d2f2a4df451eaf1dce93110b7c
document type
citation
dois
  1. 10.1093/neuonc/noab274
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34850167
immutable id
pubmed:34850167@42e6fb1f8fbcb06cb20db930c58015cad83037d2f2a4df451eaf1dce93110b7c
journal
abbreviation
Neuro Oncol
issn electronic
1523-5866
issn print
1522-8517
issue
6
name
Neuro-oncology
nlm unique id
100887420
pages
997-1007
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Neuro Oncol. 2022 Jun 1;24(6):1008-1009. doi: 10.1093/neuonc/noac048.
    note
    Source null
    related pmid
    35178549
    relationship
    Comment in
outcomes validated
false
pmid
34850167
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
affa09d727444b4396817a3510dfc249b5e7518d2cc6628fa0fa0056ae30e7b9
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Jun 1
precision
day
year
2022
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34850167/
title
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

Preserved source evidence · Not medical advice